Management tracks: Lilly, Kiadis

Eli Lilly and Co. (NYSE:LLY) said SVP and President of Lilly Oncology Sue Mahony will retire, effective Aug. 31. She is succeeded by Anne White, who is VP of portfolio management and Lilly's Chorus R&D unit. The Chorus unit specializes in virtual drug development.

Immunotherapy company Kiadis Pharma N.V. (Euronext:KDS) said CFO Robbert van Heekeren has stepped down to pursue other opportunities. He will be succeeded by Scott Holmes, who is SVP and CFO at Keryx Biopharmaceuticals Inc. (NASDAQ:KERX). Holmes plans to make the transition once Keryx completes its planned merger with Akebia Therapeutics Inc. (NASDAQ:AKBA) this year (see “Renal Plays Akebia, Keryx Merging”)...